نتائج البحث - "Bittoni, A"

1

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients

المؤلفون: Sonia Crocetti, Carolina Liguori, Michela Del Prete, Luca Cantini, Federica Pecci, Alessandro Bittoni, Giulia Mentrasti, Alessandra Mandolesi, G. Pinterpe, Antonio Zizzi, R. Bisonni, Marina Scarpelli, Riccardo Giampieri, Chiara Pellei, Rossana Berardi

المصدر: Current Oncology
Current Oncology, Vol 28, Iss 303, Pp 3525-3536 (2021)
Volume 28
Issue 5
Pages 303-3536

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd79d223ae7923b2c2b57727a3490860Test
http://europepmc.org/articles/PMC8482160Test

2

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey

المساهمون: Orsi, G., Di Marco, M., Cavaliere, A., Niger, M., Bozzarelli, S., Giordano, G., Noventa, S., Rapposelli, I. G., Garajova, I., Tortora, G., Rodriquenz, M. G., Bittoni, A., Penzo, E., De Lorenzo, S., Peretti, U., Paratore, C., Bernardini, I., Mosconi, S., Spallanzani, A., Macchini, M., Tamburini, E., Bencardino, K., Giommoni, E., Scartozzi, M., Forti, L., Valente, M. M., Militello, A. M., Cascinu, S., Milella, M., Reni, M., Orsi G., Di Marco M., Cavaliere A., Niger M., Bozzarelli S., Giordano G., Noventa S., Rapposelli I.G., Garajova I., Tortora G., Rodriquenz M.G., Bittoni A., Penzo E., De Lorenzo S., Peretti U., Paratore C., Bernardini I., Mosconi S., Spallanzani A., Macchini M., Tamburini E., Bencardino K., Giommoni E., Scartozzi M., Forti L., Valente M.M., Militello A.M., Cascinu S., Milella M., Reni M.

المصدر: ESMO Open

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c3d6ecae6dfd5240f9890e44c4b137Test

3

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial

المساهمون: Cascinu, S., Berardi, R., Bianco, R., Bilancia, D., Zaniboni, A., Ferrari, D., Mosconi, S., Spallanzani, A., Cavanna, L., Leo, S., Negri, F., Beretta, G. D., Sobrero, A., Banzi, M., Morabito, A., Bittoni, A., Marciano, R., Ferrara, D., Noventa, S., Piccirillo, M. C., Labianca, R., Mosconi, C., Casadei Gardini, A., Gallo, C., Perrone, F., Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Dari, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Gastroenterology, Deoxycytidine, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Medicine, Advanced pancreatic cancer, Nab-paclitaxel, Unresectable Pancreatic Cancer, Pancreatic Neoplasm, Combination chemotherapy, Middle Aged, Prognosis, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, Human, Adult, medicine.medical_specialty, Paclitaxel, Prognosi, Locally advanced, Adenocarcinoma, Follow-Up Studie, 03 medical and health sciences, Phase II randomized trial, Internal medicine, Albumins, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Albumin, medicine.disease, Gemcitabine, Pancreatic Neoplasms, 030104 developmental biology, Paclitaxel and gemcitabine, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c376e62a6b974a269dc1a734997b60dTest
http://hdl.handle.net/11591/461643Test

4

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

المؤلفون: Alessandra Lucarelli, Maria Giuditta Baleani, Federica Pecci, Riccardo Giampieri, Luca Cantini, Andrea Lanese, Rossana Berardi, Elena Maccaroni, Enrica Giglio, Giulia Mentrasti, Tania Meletani, Alessandro Bittoni, Valeria Sotte

المصدر: Oncology and Therapy, Vol 8, Iss 1, Pp 161-169 (2019)
Oncology and Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f0209f279480a30e4a0eb471f7a4f3Test
https://doaj.org/article/e754b4f6a03f4a02960ee3447a8bc5e7Test

5

Retrospective Comparative Analysis of KRAS G12C

المؤلفون: Riccardo Giampieri, Alessio Lupi, Pina Ziranu, Alessandro Bittoni, Andrea Pretta, Federica Pecci, Mara Persano, Enrica Giglio, Cecilia Copparoni, Sonia Crocetti, Alessandra Mandolesi, Gavino Faa, Pierpaolo Coni, Mario Scartozzi, Rossana Berardi

المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205252efaf2d65541cbd7a5ba6404a20Test
https://pubmed.ncbi.nlm.nih.gov/34660299Test

6

Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer

المؤلفون: Haojie Li, Ashwini Arunachalam, Gregory M. Lubiniecki, Ramon E. Camacho, Marisa A. Bittoni, David P. Carbone, Xiting Cao, Yichen Zhong

المصدر: Clinical Lung Cancer. 19:e783-e799

مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cost-Benefit Analysis, medicine.medical_treatment, Adenocarcinoma, Medicare, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Salvage Therapy, Chemotherapy, business.industry, Retrospective cohort study, Prognosis, medicine.disease, United States, Gemcitabine, Carboplatin, Survival Rate, 030104 developmental biology, Pemetrexed, chemistry, Docetaxel, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Carcinoma, Large Cell, Female, business, Follow-Up Studies, SEER Program, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761d8d6bf8abef28d83a587fc3e50bfdTest
https://doi.org/10.1016/j.cllc.2018.05.016Test

7

PD-5 Retrospective comparative analysis of K-ras G12C vs other K-ras mutations in metastatic colorectal cancer patients treated with first-line chemotherapy doublet + bevacizumab

المؤلفون: Federica Pecci, Mara Persano, Pina Ziranu, Alessandra Mandolesi, Enrica Giglio, Alessio Lupi, Andrea Pretta, Riccardo Giampieri, Alessandro Bittoni, R. Berardi, Sonia Crocetti, Mario Scartozzi

المصدر: Annals of Oncology. 32:S200

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Colorectal cancer, Internal medicine, medicine, Hematology, First line chemotherapy, business, medicine.disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8748363a1a34b9f9b192d3adbab354e5Test
https://doi.org/10.1016/j.annonc.2021.05.023Test

8

Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)

المؤلفون: David P. Carbone, Marisa A. Bittoni, Randall E. Harris

المصدر: Molecular and Clinical Oncology. 6:917-920

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e872641ce9f54b23f35c87a2ffec83dTest
https://doi.org/10.3892/mco.2017.1239Test

9

Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial

المصدر: Annals of Oncology. 30:v253-v254

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7abcaf8899ee5708aa23c12157d6724fTest
https://doi.org/10.1093/annonc/mdz247.001Test

10

Medical treatment for cholangiocarcinoma

المؤلفون: Alessandro Bittoni, Maximiliano Salati, Adelaida La Casta, Julien Edeline, Jordi Bruix, Jorge Adeva, R. Berardi, Juan W. Valle, Bruno Sangro

المصدر: Adeva, J, Sangro, B, Salati, M, Edeline, J, La Casta, A, Bittoni, A, Berardi, R, Bruix, J & Valle, J W 2019, ' Medical treatment for cholangiocarcinoma ', Liver International, vol. 39, no. S1, pp. 123-142 . https://doi.org/10.1111/liv.14100Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, chemotherapy, Deoxycytidine, Targeted therapy, law.invention, Capecitabine, Cholangiocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Growth factor receptor, Randomized controlled trial, law, Internal medicine, biliary tract cancer, Clinical endpoint, medicine, Humans, Molecular Targeted Therapy, Phosphoinositide-3 Kinase Inhibitors, Randomized Controlled Trials as Topic, Chemotherapy, Hepatology, business.industry, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, targeted therapy, Receptors, Fibroblast Growth Factor, Gemcitabine, Isocitrate Dehydrogenase, Histone Deacetylase Inhibitors, Clinical research, Bile Duct Neoplasms, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Immunotherapy, immunotherapy, Cisplatin, business, cholangiocarcinoma, medicine.drug

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ccf109d0c0d45a2fd8c3cb202b22f60Test
https://pure.manchester.ac.uk/ws/files/87719512/2019_04_03_Medical_treatment_for_cholangiocarcinoma_Author_Accepeted_Manuscript_.docxTest

تنقيح النتائج